BR0109022A - Método de preparação de citalopram e sua composição farmacêutica - Google Patents

Método de preparação de citalopram e sua composição farmacêutica

Info

Publication number
BR0109022A
BR0109022A BR0109022-4A BR0109022A BR0109022A BR 0109022 A BR0109022 A BR 0109022A BR 0109022 A BR0109022 A BR 0109022A BR 0109022 A BR0109022 A BR 0109022A
Authority
BR
Brazil
Prior art keywords
citalopram
halogen
preparation
formula
dimethylamine
Prior art date
Application number
BR0109022-4A
Other languages
English (en)
Inventor
Michael Harold Rock
Haleh Ahmadian
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of BR0109022A publication Critical patent/BR0109022A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87Benzo [c] furans; Hydrogenated benzo [c] furans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

"MéTODO DE PREPARAçãO DE CITALOPRAM E SUA COMPOSIçãO FARMACêUTICA". A invenção refere-se a um método para a preparação de citalopram compreendendo a reação de um composto da fórmula (II) bom um composto tendo a fórmula (III) onde R é halogênio ou -O-SO~ 2~-X, onde X é alquila, alquenila, alquinila ou opcionalmente a alquila é arila ou aralquila substituída e R^ 1^ é dimetilamina, halogênio ou -O-SO~ 2-X onde X é como definido acima, desde que R não seja halogênio quando R^ 1^ for dimetilamina; e se R^ 1^ for dimetilamina seguida pelo isolamento de base do citalopram ou sal com adição de ácido farmacêuticamente aceitável do mesmo, e se R^ 1^ for halogênio ou -OSO~ 2~-X onde X é como definido acima, seguido pela conversão do composto resultante da fórmula onde R^ 2^ é halogênio ou um grupo da fórmula -O-SO~ 2~-X onde X é como definido acima, para o citalopram seguido pelo isolamento de base do citalopram ou um sal com adição de ácido farmacêuticamente aceitável do mesmo.
BR0109022-4A 2000-03-03 2001-03-01 Método de preparação de citalopram e sua composição farmacêutica BR0109022A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200000353 2000-03-03
PCT/DK2001/000140 WO2001051478A1 (en) 2000-03-03 2001-03-01 Method for the preparation of citalopram

Publications (1)

Publication Number Publication Date
BR0109022A true BR0109022A (pt) 2003-06-03

Family

ID=8159277

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0109022-4A BR0109022A (pt) 2000-03-03 2001-03-01 Método de preparação de citalopram e sua composição farmacêutica

Country Status (29)

Country Link
US (1) US6768011B2 (pt)
EP (1) EP1263750A1 (pt)
JP (1) JP2003519692A (pt)
KR (1) KR20020080450A (pt)
CN (1) CN1411454A (pt)
AR (1) AR027559A1 (pt)
AU (1) AU2001240469A1 (pt)
BE (1) BE1011481A6 (pt)
BG (1) BG107050A (pt)
BR (1) BR0109022A (pt)
CA (1) CA2401374A1 (pt)
EA (1) EA005491B1 (pt)
FR (1) FR2805814A1 (pt)
GR (1) GR1003795B (pt)
HR (1) HRP20020742A2 (pt)
HU (1) HUP0300060A3 (pt)
IE (1) IES20010157A2 (pt)
IL (1) IL151467A0 (pt)
IS (1) IS6526A (pt)
IT (1) ITMI20010444A1 (pt)
MX (1) MXPA02008634A (pt)
NL (1) NL1017417C1 (pt)
NO (1) NO20024180D0 (pt)
NZ (1) NZ521200A (pt)
PL (1) PL358543A1 (pt)
SK (1) SK14152002A3 (pt)
TR (1) TR200202096T2 (pt)
WO (1) WO2001051478A1 (pt)
ZA (1) ZA200206846B (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE237604T1 (de) * 1999-04-14 2003-05-15 Lundbeck & Co As H Verfahren zur herstellung von citalopram
IES20010157A2 (en) 2000-03-03 2002-03-06 Lundbeck & Co As H Method for the preparation of citalopram
GB0005477D0 (en) 2000-03-07 2000-04-26 Resolution Chemicals Limited Process for the preparation of citalopram
CA2402553A1 (en) 2000-03-13 2001-09-20 H. Lundbeck A/S Stepwise alkylation of 5-substituted 1-(4-fluorophenyl)-1,3-dihydroisobenzofurans
BR0109176A (pt) 2000-03-13 2003-04-22 Lundbeck & Co As H Método para preparação de citalopram e composto da fórmula
IES20010206A2 (en) 2000-03-13 2002-03-06 Lundbeck & Co As H Method for the preparation of citalopram
IL151488A0 (en) 2000-03-14 2003-04-10 Lundbeck & Co As H Method for the preparation of citalopram
AR032455A1 (es) 2000-05-12 2003-11-12 Lundbeck & Co As H Metodo para la preparacion de citalopram, un intermediario empleado en el metodo, un metodo para la preparacion del intermediario empleado en el metodo y composicion farmaceutica antidepresiva
MXPA04004368A (es) * 2001-11-08 2004-08-11 Sepracor Inc Metodos para tratar depresion y otros transtornos del sistema nervioso central utilizando desmetil-y didesmetil-metabolitos del citalopram enantiomericamente enriquecidos.
PE20040991A1 (es) 2002-08-12 2004-12-27 Lundbeck & Co As H Separacion de intermediarios para la preparacion de escitalopram
US20050154052A1 (en) * 2003-03-24 2005-07-14 Hetero Drugs Limited Novel crystalline forms of (s)-citalopram oxalate
TWI339651B (en) 2004-02-12 2011-04-01 Lundbeck & Co As H Method for the separation of intermediates which may be used for the preparation of escitalopram
GB0601286D0 (en) 2006-01-23 2006-03-01 Sandoz Ag Asymmetric synthesis

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1143702A (pt) 1965-03-18
GB1526331A (en) 1976-01-14 1978-09-27 Kefalas As Phthalanes
GB8419963D0 (en) 1984-08-06 1984-09-12 Lundbeck & Co As H Intermediate compound and method
GB8814057D0 (en) * 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
US5296507A (en) 1990-09-06 1994-03-22 H.Lundbeck A/S Treatment of cerbrovascular disorders
DE19626659A1 (de) 1996-07-03 1998-01-08 Basf Ag Verfahren zur Herstellung von Phthaliden
DE19627697A1 (de) 1996-07-10 1998-01-15 Basf Ag Verfahren zur Herstellung von Phthaliden
JP3526581B2 (ja) 1997-07-08 2004-05-17 ハー・ルンドベック・アクティーゼルスカブ シタロプラムの製造方法
UA62985C2 (en) 1997-11-10 2004-01-15 Lunnbeck As H A method for the preparation of citalopram
CZ292911B6 (cs) 1997-11-11 2004-01-14 H. Lundbeck A/S Způsob výroby citalopramu
PL199423B1 (pl) 1998-10-20 2008-09-30 Lundbeck & Co As H Sposób wytwarzania citalopramu
TR200101796T2 (tr) 1998-12-23 2001-11-21 H. Lundbeck A/S 5-Siyanofitalitin preparasyonuna yönelik metot
AR022329A1 (es) 1999-01-29 2002-09-04 Lundbeck & Co As H Metodo para la preparacion de 5-cianoftalida
ATE237604T1 (de) 1999-04-14 2003-05-15 Lundbeck & Co As H Verfahren zur herstellung von citalopram
ITMI991579A1 (it) 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
ITMI991581A1 (it) 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
ITMI991486A1 (it) 1999-07-06 2001-01-06 Vis Farmaceutici S P A Processo per la sintesi di citalopram
GB2360281B (en) 1999-10-25 2002-01-16 Lundbeck & Co As H Method for the preparation of citalopram
AR026063A1 (es) 1999-11-01 2002-12-26 Lundbeck & Co As H Metodo para la preparacion de 5-carboxiftalida.
US6310222B1 (en) 1999-11-01 2001-10-30 Sumika Fine Chemicals Co., Ltd. Production method of 5-phthalancarbonitrile compound, intermediate therefor and production method of the intermediate
WO2001047909A1 (en) 1999-12-28 2001-07-05 H. Lundbeck A/S Method for the preparation of citalopram
PL198803B1 (pl) 1999-12-30 2008-07-31 Lundbeck & Co As H Sposób wytwarzania 5-cyjano-3H-izobenzofuran-1-onu
ES2206177T3 (es) 2000-01-14 2004-05-16 H. Lundbeck A/S Metodo para la preparacion de 5-cianoftalida.
IT1317729B1 (it) 2000-01-18 2003-07-15 Norpharma S P A Procedimento per la preparazione della 5-carbossiftalide.
US6433196B1 (en) 2000-02-17 2002-08-13 Sumika Fine Chemicals Co., Ltd. Production method of citalopram, intermediate therefor and production method of the intermediate
IES20010143A2 (en) 2000-02-24 2001-07-25 Lundbeck & Co As H Method for the preparation of citalopram
NL1017415C1 (nl) * 2000-02-24 2001-05-18 Lundbeck & Co As H Werkwijze voor de bereiding van Citalopram.
IES20010157A2 (en) 2000-03-03 2002-03-06 Lundbeck & Co As H Method for the preparation of citalopram
GB0005477D0 (en) 2000-03-07 2000-04-26 Resolution Chemicals Limited Process for the preparation of citalopram
CA2402553A1 (en) 2000-03-13 2001-09-20 H. Lundbeck A/S Stepwise alkylation of 5-substituted 1-(4-fluorophenyl)-1,3-dihydroisobenzofurans
IES20010206A2 (en) 2000-03-13 2002-03-06 Lundbeck & Co As H Method for the preparation of citalopram
BR0109176A (pt) 2000-03-13 2003-04-22 Lundbeck & Co As H Método para preparação de citalopram e composto da fórmula
GB2357762B (en) 2000-03-13 2002-01-30 Lundbeck & Co As H Crystalline base of citalopram
IL151488A0 (en) 2000-03-14 2003-04-10 Lundbeck & Co As H Method for the preparation of citalopram
EP1274699A1 (en) 2000-03-16 2003-01-15 H. Lundbeck A/S Method for the preparation of 5-cyano-1-(4-fluorophenyl)-1,3-dihydroisobenzofurans
AR032455A1 (es) 2000-05-12 2003-11-12 Lundbeck & Co As H Metodo para la preparacion de citalopram, un intermediario empleado en el metodo, un metodo para la preparacion del intermediario empleado en el metodo y composicion farmaceutica antidepresiva
EA200200332A1 (ru) 2000-07-06 2002-06-27 Х.Лундбекк А/С Способ получения циталопрама
CA2354880C (en) 2000-08-18 2003-06-03 H. Lundbeck A/S Method for the preparation of citalopram
IL147226A (en) 2000-12-22 2006-04-10 Lundbeck & Co As H Process for the preparation of pure cithalopram
PT1181272E (pt) 2000-12-28 2003-01-31 Lundbeck & Co As H Processo para a preparacao de citalopram puro

Also Published As

Publication number Publication date
NO20024180L (no) 2002-09-02
MXPA02008634A (es) 2003-02-24
AR027559A1 (es) 2003-04-02
AU2001240469A1 (en) 2001-07-24
GR1003795B (el) 2002-02-08
PL358543A1 (en) 2004-08-09
HUP0300060A3 (en) 2005-02-28
KR20020080450A (ko) 2002-10-23
WO2001051478A1 (en) 2001-07-19
US20030092761A1 (en) 2003-05-15
IES20010157A2 (en) 2002-03-06
BE1011481A6 (fr) 2001-07-03
EP1263750A1 (en) 2002-12-11
NZ521200A (en) 2004-03-26
IL151467A0 (en) 2003-04-10
IS6526A (is) 2002-08-27
CN1411454A (zh) 2003-04-16
CA2401374A1 (en) 2001-07-19
BG107050A (en) 2003-05-30
TR200202096T2 (tr) 2003-01-21
SK14152002A3 (sk) 2003-03-04
ITMI20010444A1 (it) 2002-09-05
ZA200206846B (en) 2003-08-27
EA200200939A1 (ru) 2003-02-27
HUP0300060A2 (en) 2003-05-28
US6768011B2 (en) 2004-07-27
NO20024180D0 (no) 2002-09-02
NL1017417C1 (nl) 2001-03-16
FR2805814A1 (fr) 2001-09-07
HRP20020742A2 (en) 2004-02-29
EA005491B1 (ru) 2005-02-24
JP2003519692A (ja) 2003-06-24

Similar Documents

Publication Publication Date Title
BR9917367A (pt) Método para preparação de citalopram e sua composição farmacêutica
BR0108947A (pt) Método para preparação e citalopram; intermediário e sua composição farmacêutica
IS6859A (is) Kristölluð form atorvastatíns
BR0109022A (pt) Método de preparação de citalopram e sua composição farmacêutica
BR0213877A (pt) Compostos orgânicos
BR0212185A (pt) Compostos e métodos para a preparação de compostos
DK0891325T3 (da) Para-substituerede phenylpropansyrederivater som integrinantagonister
BR0010520A (pt) Novos compostos farmaceuticamente ativos
YU56995A (sh) Soli derivata indola
MX9100990A (es) Compuesto monohidrato de furoato de mometasona,al procedimiento para su preparacion y a las composiciones farmaceuticas
MX9304571A (es) Compuestos fanilicos ligados a un arilo o heteroarilo mediante un radical alifatico o un atomo heterogeneo que contiene un grupo eslabonador.
BR0108871A (pt) Composto, processo de preparação de compostos, e, composição farmacêutica
BR0010555A (pt) Inibidores de neuraminidases
BR0114436A (pt) Composto com anel de cinco elementos contendo nitrogênio alifático
ES2147230T3 (es) Derivados de aminoacidos, medicamentos que contienen a estos compuestos y procedimiento para su preparacion.
ES8303528A1 (es) Un procedimiento para la preparacion de nuevos derivados de los compuestos c-076
EA200300716A1 (ru) Гетероциклилалкилиндольные или -азаиндольные соединения в качестве лиганд 5-гидрокситриптамина-6
DE3665711D1 (de) Novel guanidinomethylbenzoic acid derivatives
ATE279411T1 (de) Fluorszierende marker
EA200000431A2 (ru) Новые замещенные димерные соединения, способ их получения и фармацевтические композиции, содержащие их
ES528561A0 (es) Un procedimiento para la preparacion de compuestos nitro alifaticos
BR0014461A (pt) Composto e método para preparar o mesmo
BR9713951A (pt) Processo para preparação de 3-hidroxipirazóis n-substituìdos.
BR0109267A (pt) Método para preparação de citalopram; composto e sua composição farmacêutica
ES2058752T3 (es) Derivados de tiazol.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1963 DE 19.08.2008.